Diabetes After Pancreatic Surgery: Novel Issues

  • Marina Scavini
  • Erica Dugnani
  • Valentina Pasquale
  • Daniela Liberati
  • Francesca Aleotti
  • Gaetano Di Terlizzi
  • Giovanna Petrella
  • Gianpaolo Balzano
  • Lorenzo PiemontiEmail author
Other Forms of Diabetes (R Bonadonna, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Other Forms of Diabetes


In the developed world, pancreatic surgery is becoming more common, with an increasing number of patients developing diabetes because of either partial or total pancreatectomy, with a significant impact on quality of life and survival. Although these patients are expected to consume increasing health care resources in the near future, many aspects of diabetes after pancreatectomy are still not well defined. The treatment of diabetes in these patients takes advantage of the therapies used in type 1 and 2 diabetes; however, no specific guidelines for its management, both immediately after pancreatic surgery or in the long term, have been developed. In this article, on the basis of both the literature and our clinical experience, we address the open issues and discuss the most appropriate therapeutic options for patients with diabetes after pancreatectomy.


Pancreatectomy Pancreatogenic diabetes Pancreatic cancer Islet autotransplantation 



This study was supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC, bando 5 × 1000 N_12182 and Progetto IGN_ 11783).

Compliance with Ethics Guidelines

Conflict of Interest

Marina Scavini reports personal fees and non-financial support from Roche Diagnostics.

Erica Dugnani, Valentina Pasquale, Daniela Liberati, Francesca Aleotti, Gaetano Di Terlizzi, Giovanna Petrella, Gianpaolo Balzano, and Lorenzo Piemonti declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Busnardo AC, DiDio LJ, Tidrick RT, Thomford NR. History of the pancreas. Am J Surg. 1983;146:539–50.PubMedGoogle Scholar
  2. 2.
    Bassi C, Malleo G. The unsolved mystery of Johann Georg Wirsung and of (his?) pancreatic duct. Surgery. 2011;149:153–5.PubMedGoogle Scholar
  3. 3.
    Jolles S. Paul Langerhans. J Clin Pathol. 2002;55:243.PubMedCentralPubMedGoogle Scholar
  4. 4.
    Are C, Dhir M, Ravipati L. History of pancreaticoduodenectomy: early misconceptions, initial milestones and the pioneers. HPB (Oxford). 2011;13:377–84.Google Scholar
  5. 5.
    Whipple AO, Parsons WB, Mullins CR. Treatment of carcinoma of the ampulla of vater. Ann Surg. 1935;102:763–79.PubMedCentralPubMedGoogle Scholar
  6. 6.
    Luft R. Oskar Minkowski: discovery of the pancreatic origin of diabetes, 1889. Diabetologia. 1989;32:399–401.PubMedGoogle Scholar
  7. 7.
    The Nobel Lecture on Diabetes and Insulin. Can Med Assoc J. 1926; 16:301.Google Scholar
  8. 8.
    Roe BA. Frederick Sanger (1918–2013). Genome Res. 2014;24:xi–xii.PubMedCentralPubMedGoogle Scholar
  9. 9.
    Priestley JT, Comfort MW, Sprague RG. Total pancreatectomy for hyperinsulinism due to islet-cell adenoma; follow-up report 5 1/2 years after operation, including matabolic studies. Ann Surg. 1949;130:211–7.PubMedCentralPubMedGoogle Scholar
  10. 10.
    Lahat G, Ben Haim M, Nachmany I, et al. Pancreatic incidentalomas: high rate of potentially malignant tumors. J Am Coll Surg. 2009;209:313–9.PubMedGoogle Scholar
  11. 11.
    Lemmens VE, Bosscha K, van der Schelling G, et al. Improving outcome for patients with pancreatic cancer through centralization. Br J Surg. 2011;98:1455–62.PubMedGoogle Scholar
  12. 12.
    Balzano G, Zerbi A, Capretti G, et al. Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy. Br J Surg. 2008;95:357–62.PubMedGoogle Scholar
  13. 13.
    Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2007;142:761–8.PubMedGoogle Scholar
  14. 14.
    Wente MN, Veit JA, Bassi C, et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery. 2007;142:20–5.PubMedGoogle Scholar
  15. 15.•
    Harnoss JC, Ulrich AB, Harnoss JM, et al. Use and results of consensus definitions in pancreatic surgery: a systematic review. Surgery. 2014;155:47–57. A good review about the definition of complication after pancreatic surgery.PubMedGoogle Scholar
  16. 16.
    Bliss LA, Yang CJ, Chau Z et al. Patient selection and the volume effect in pancreatic surgery: unequal benefits? HPB (Oxford). 2014.Google Scholar
  17. 17.
    Donahue TR, Reber HA. Pancreatic surgery. Curr Opin Gastroenterol. 2013;29:552–8.PubMedGoogle Scholar
  18. 18.
    Schmidt CM, Turrini O, Parikh P, et al. Effect of hospital volume, surgeon experience, and surgeon volume on patient outcomes after pancreaticoduodenectomy: a single-institution experience. Arch Surg. 2010;145:634–40.PubMedGoogle Scholar
  19. 19.
    Gooiker GA, Lemmens VE, Besselink MG, et al. Impact of centralization of pancreatic cancer surgery on resection rates and survival. Br J Surg. 2014;101:1000–5.PubMedGoogle Scholar
  20. 20.
    Yoshioka R, Yasunaga H, Hasegawa K, et al. Impact of hospital volume on hospital mortality, length of stay and total costs after pancreaticoduodenectomy. Br J Surg. 2014;101:523–9.PubMedGoogle Scholar
  21. 21.•
    Mohammed S, Van Buren IG, Fisher WE. Pancreatic cancer: advances in treatment. World J Gastroenterol. 2014;20:9354–60. A good review about the advances in treatment of pancreatic cancer.PubMedCentralPubMedGoogle Scholar
  22. 22.
    Hackert T, Buchler MW. Pancreatic cancer: advances in treatment, results and limitations. Dig Dis. 2013;31:51–6.PubMedGoogle Scholar
  23. 23.
    van der Gaag NA, Berkhemer OA, Sprangers MA, et al. Quality of life and functional outcome after resection of pancreatic cystic neoplasm. Pancreas. 2014;43:755–61.PubMedGoogle Scholar
  24. 24.
    Park JW, Jang JY, Kim EJ, et al. Effects of pancreatectomy on nutritional state, pancreatic function and quality of life. Br J Surg. 2013;100:1064–70.PubMedGoogle Scholar
  25. 25.
    Velanovich V. The association of quality-of-life measures with malignancy and survival in patients with pancreatic pathology. Pancreas. 2011;40:1063–9.PubMedGoogle Scholar
  26. 26.
    Pezzilli R, Falconi M, Zerbi A, et al. Clinical and patient-reported outcomes after pancreatoduodenectomy for different diseases: a follow-up study. Pancreas. 2011;40:938–45.PubMedGoogle Scholar
  27. 27.
    Halloran CM, Cox TF, Chauhan S, et al. Partial pancreatic resection for pancreatic malignancy is associated with sustained pancreatic exocrine failure and reduced quality of life: a prospective study. Pancreatology. 2011;11:535–45.PubMedGoogle Scholar
  28. 28.•
    Balzano G, Piemonti L. Autologous islet transplantation in patients requiring pancreatectomy for neoplasm. Curr Diab Rep. 2014;14:512. A good review about islet autotransplantation after pancreatectomy for pancreatic neoplasm.PubMedGoogle Scholar
  29. 29.•
    Balzano G, Dugnani E, Pasquale V et al. Clinical signature and pathogenetic factors of diabetes associated with pancreas disease (T3cDM): a prospective observational study in surgical patients. Acta Diabetol. 2014. A prospective observational study about diabetes after pancreatic surgery. Google Scholar
  30. 30.
    Alberti K. Diabetes secondary to pancreatopathy: an example of brittle diabetes. In: Diabetes Secondary to Pancreatopathy. International Congress Series 762. A. Tiengo KGMMA, DelPrato S, Vranic M (Eds) Amsterdam: Excerpta Medica; 1988. pp. 7–20.Google Scholar
  31. 31.
    Billings BJ, Christein JD, Harmsen WS, et al. Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up? J Gastrointest Surg. 2005;9:1059–66. discussion 1066–7.PubMedGoogle Scholar
  32. 32.
    Kahl S, Malfertheiner P. Exocrine and endocrine pancreatic insufficiency after pancreatic surgery. Best Pract Res Clin Gastroenterol. 2004;18:947–55.PubMedGoogle Scholar
  33. 33.
    Jethwa P, Sodergren M, Lala A, et al. Diabetic control after total pancreatectomy. Dig Liver Dis. 2006;38:415–9.PubMedGoogle Scholar
  34. 34.
    Hutchins RR, Hart RS, Pacifico M, et al. Long-term results of distal pancreatectomy for chronic pancreatitis in 90 patients. Ann Surg. 2002;236:612–8.PubMedCentralPubMedGoogle Scholar
  35. 35.
    Hutchins RR, Kojodjojo P, Ho R, et al. Short and long-term outcome of pancreatic surgery in a district general hospital. J R Coll Surg Edinb. 2002;47:548–51.PubMedGoogle Scholar
  36. 36.
    Muller MW, Friess H, Kleeff J, et al. Is there still a role for total pancreatectomy? Ann Surg. 2007;246:966–74. discussion 974–5.PubMedGoogle Scholar
  37. 37.
    Stauffer JA, Nguyen JH, Heckman MG, et al. Patient outcomes after total pancreatectomy: a single centre contemporary experience. HPB (Oxford). 2009;11:483–92.Google Scholar
  38. 38.
    Reddy S, Wolfgang CL, Cameron JL, et al. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival. Ann Surg. 2009;250:282–7.PubMedGoogle Scholar
  39. 39.
    Sakata N, Egawa S, Motoi F, et al. Institutional indications for islet transplantation after total pancreatectomy. J Hepatobiliary Pancreat Surg. 2008;15:488–92.PubMedGoogle Scholar
  40. 40.
    Gaia E, Salacone P. Medical complications of pancreatic resections. JOP. 2007;8:114–7.PubMedGoogle Scholar
  41. 41.
    Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014; 37(Suppl 1):S81-90.Google Scholar
  42. 42.
    Andersen DK, Andren-Sandberg A, Duell EJ, et al. Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop. Pancreas. 2013;42:1227–37.PubMedGoogle Scholar
  43. 43.
    Roberts KJ, Blanco G, Webber J et al. How severe is diabetes after total pancreatectomy? A case-matched analysis. HPB (Oxford). 2013.Google Scholar
  44. 44.•
    Cui Y, Andersen DK. Pancreatogenic diabetes: special considerations for management. Pancreatology. 2011;11:279–94. A good review about pancreatogenic diabetes.PubMedGoogle Scholar
  45. 45.•
    Maeda H, Hanazaki K. Pancreatogenic diabetes after pancreatic resection. Pancreatology. 2011;11:268–76. A good review about diabetes after pancreatic resection.PubMedGoogle Scholar
  46. 46.
    Cui Y, Andersen DK. Diabetes and pancreatic cancer. Endocr Relat Cancer. 2012;19:F9–F26.PubMedGoogle Scholar
  47. 47.
    Del Prato S, Riva F, Devide A, et al. Glucagon levels and ketogenesis in human diabetes following total or partial pancreatectomy and severe chronic pancreatitis. Acta Diabetol Lat. 1980;17:111–8.PubMedGoogle Scholar
  48. 48.
    Del Prato S, Tiengo A, Baccaglini U, et al. Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy. Diabetologia. 1983;25:252–9.PubMedGoogle Scholar
  49. 49.
    Polonsky KS, Herold KC, Gilden JL, et al. Glucose counterregulation in patients after pancreatectomy. Comparison with other clinical forms of diabetes. Diabetes. 1984;33:1112–9.PubMedGoogle Scholar
  50. 50.
    Del Prato S, Vigili de Kreutzenberg S, Trevisan R, et al. Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy. Diabetologia. 1985;28:277–81.PubMedGoogle Scholar
  51. 51.
    Vigili de Kreutzenberg S, Maifreni L, Lisato G, et al. Glucose turnover and recycling in diabetes secondary to total pancreatectomy: effect of glucagon infusion. J Clin Endocrinol Metab. 1990;70:1023–9.PubMedGoogle Scholar
  52. 52.
    Lee BW, Kang HW, Heo JS, et al. Insulin secretory defect plays a major role in the development of diabetes in patients with distal pancreatectomy. Metabolism. 2006;55:135–41.PubMedGoogle Scholar
  53. 53.
    Chen N, Unnikrishnan IR, Anjana RM, et al. The complex exocrine-endocrine relationship and secondary diabetes in exocrine pancreatic disorders. J Clin Gastroenterol. 2011;45:850–61.PubMedGoogle Scholar
  54. 54.
    Slezak LA, Andersen DK. Pancreatic resection: effects on glucose metabolism. World J Surg. 2001;25:452–60.PubMedGoogle Scholar
  55. 55.
    Nosadini R, del Prato S, Tiengo A, et al. Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes. Diabetes. 1982;31:346–55.PubMedGoogle Scholar
  56. 56.
    Gall FP, Muhe E, Gebhardt C. Results of partial and total pancreaticoduodenectomy in 117 patients with chronic pancreatitis. World J Surg. 1981;5:269–75.PubMedGoogle Scholar
  57. 57.
    Muggeo M, Moghetti P, Faronato PP, et al. Insulin receptors on circulating blood cells from patients with pancreatogenic diabetes: a comparison with type I diabetes and normal subjects. J Endocrinol Invest. 1987;10:311–9.PubMedGoogle Scholar
  58. 58.
    Seymour NE, Volpert AR, Lee EL, et al. Alterations in hepatocyte insulin binding in chronic pancreatitis: effects of pancreatic polypeptide. Am J Surg. 1995;169:105–9. discussion 110.PubMedGoogle Scholar
  59. 59.
    Inoue K, Tobe T, Suzuki T, et al. Plasma cholecystokinin and pancreatic polypeptide response after radical pancreatoduodenectomy with Billroth I and Billroth II type of reconstruction. Ann Surg. 1987;206:148–54.PubMedCentralPubMedGoogle Scholar
  60. 60.
    Sive A, Vinik AI, Van Tonder S, Lund A. Impaired pancreatic polypeptide secretion in chronic pancreatitis. J Clin Endocrinol Metab. 1978;47:556–9.PubMedGoogle Scholar
  61. 61.
    Adrian TE, McKiernan J, Johnstone DI, et al. Hormonal abnormalities of the pancreas and gut in cystic fibrosis. Gastroenterology. 1980;79:460–5.PubMedGoogle Scholar
  62. 62.
    Andersen DK, Ruiz CL, Burant CF. Insulin regulation of hepatic glucose transporter protein is impaired in chronic pancreatitis. Ann Surg. 1994;219:679–86. discussion 686–7.PubMedCentralPubMedGoogle Scholar
  63. 63.
    Seymour NE, Spector SA, Andersen DK, et al. Overexpression of hepatic pancreatic polypeptide receptors in chronic pancreatitis. J Surg Res. 1998;76:47–52.PubMedGoogle Scholar
  64. 64.
    Bajorunas DR, Fortner JG, Jaspan J, Sherwin RS. Total pancreatectomy increases the metabolic response to glucagon in humans. J Clin Endocrinol Metab. 1986;63:439–46.PubMedGoogle Scholar
  65. 65.
    Schrader H, Menge BA, Breuer TG, et al. Impaired glucose-induced glucagon suppression after partial pancreatectomy. J Clin Endocrinol Metab. 2009;94:2857–63.PubMedGoogle Scholar
  66. 66.
    Donowitz M, Hendler R, Spiro HM, et al. Glucagon secretion in acute and chronic pancreatitis. Ann Intern Med. 1975;83:778–81.PubMedGoogle Scholar
  67. 67.
    Linehan IP, Lambert MA, Brown DC, et al. Total pancreatectomy for chronic pancreatitis. Gut. 1988;29:358–65.PubMedCentralPubMedGoogle Scholar
  68. 68.
    Ewald N, Bretzel RG, Fantus IG, et al. Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial. Diabetes Metab Res Rev. 2007;23:386–91.PubMedGoogle Scholar
  69. 69.
    Muscogiuri G, Mezza T, Prioletta A, et al. Removal of duodenum elicits GLP-1 secretion. Diabetes Care. 2013;36:1641–6.PubMedCentralPubMedGoogle Scholar
  70. 70.
    Korner J, Bessler M, Inabnet W, et al. Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis. 2007;3:597–601.PubMedCentralPubMedGoogle Scholar
  71. 71.
    Holst JJ. On the physiology of GIP and GLP-1. Horm Metab Res. 2004;36:747–54.PubMedGoogle Scholar
  72. 72.
    Knop FK, Vilsboll T, Larsen S, et al. Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution. Am J Physiol Endocrinol Metab. 2007;292:E324–30.PubMedGoogle Scholar
  73. 73.
    Ewald N, Bretzel RG. Diabetes mellitus secondary to pancreatic diseases (Type 3c)—are we neglecting an important disease? Eur J Intern Med. 2013;24:203–6.PubMedGoogle Scholar
  74. 74.
    Ewald N, Kaufmann C, Raspe A, et al. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev. 2012;28:338–42.PubMedGoogle Scholar
  75. 75.
    Ito T, Otsuki M, Igarashi H, et al. Epidemiological study of pancreatic diabetes in Japan in 2005: a nationwide study. Pancreas. 2010;39:829–35.PubMedGoogle Scholar
  76. 76.
    Hardt PD, Brendel MD, Kloer HU, Bretzel RG. Is pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed? Diabetes Care. 2008;31 Suppl 2:S165–9.PubMedGoogle Scholar
  77. 77.
    Murphy MM, Knaus 2nd WJ, Ng SC, et al. Total pancreatectomy: a national study. HPB (Oxford). 2009;11:476–82.Google Scholar
  78. 78.••
    De Bruijn KM, van Eijck CH. New-onset diabetes after distal pancreatectomy: a systematic review. Ann Surg. 2014.A meta-analysis about diabetes incidence after partial pancreatectomy. Google Scholar
  79. 79.
    Sauvanet A. Functional results of pancreatic surgery. Rev Prat. 2002;52:1572–5.PubMedGoogle Scholar
  80. 80.
    Duron F, Duron JJ. [Pancreatectomy and diabetes]. Ann Chir. 1999;53:406–11.PubMedGoogle Scholar
  81. 81.
    Dresler CM, Fortner JG, McDermott K, Bajorunas DR. Metabolic consequences of (regional) total pancreatectomy. Ann Surg. 1991;214:131–40.PubMedCentralPubMedGoogle Scholar
  82. 82.
    Kiviluoto T, Schroder T, Karonen SL, et al. Glycemic control and serum lipoproteins after total pancreatectomy. Ann Clin Res. 1985;17:110–5.PubMedGoogle Scholar
  83. 83.
    Piorkowski RJ, Blievernicht SW, Lawrence Jr W, et al. Pancreatic and periampullary carcinoma. Experience with 200 patients over a 12 year period. Am J Surg. 1982;143:189–93.PubMedGoogle Scholar
  84. 84.
    Forssmann K, Schirr K, Schmid M, et al. [Postoperative follow-up in patients with partial Whipple duodenopancreatectomy for chronic pancreatitis]. Z Gastroenterol. 1997;35:1071–80.PubMedGoogle Scholar
  85. 85.
    Heise JW, Katoh M, Luthen R, Roher HD. Long-term results following different extent of resection in chronic pancreatitis. Hepatogastroenterology. 2001;48:864–8.PubMedGoogle Scholar
  86. 86.
    Warren KW, Poulantzas JK, Kune GA. Life after total pancreatectomy for chronic pancreatitis: clinical study of eight cases. Ann Surg. 1966;164:830–4.PubMedCentralPubMedGoogle Scholar
  87. 87.
    Sato T, Noto N, Matsuno S, Miyakawa K. Follow-up results of surgical treatment for chronic pancreatitis. Present status in Japan. Am J Surg. 1981;142:317–23.PubMedGoogle Scholar
  88. 88.
    Bittner R, Butters M, Buchler M, et al. Glucose homeostasis and endocrine pancreatic function in patients with chronic pancreatitis before and after surgical therapy. Pancreas. 1994;9:47–53.PubMedGoogle Scholar
  89. 89.
    Boyle PJ, Kempers SF, O’Connor AM, Nagy RJ. Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus. N Engl J Med. 1995;333:1726–31.PubMedGoogle Scholar
  90. 90.
    Dammann HG, Besterman HS, Bloom SR, Schreiber HW. Gut-hormone profile in totally pancreatectomised patients. Gut. 1981;22:103–7.PubMedCentralPubMedGoogle Scholar
  91. 91.
    Buchler MW, Friess H, Muller MW, et al. Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancreatitis. Am J Surg. 1995;169:65–9. discussion 69–70.PubMedGoogle Scholar
  92. 92.
    Epelboym I, Winner M, DiNorcia J, et al. Quality of life in patients after total pancreatectomy is comparable with quality of life in patients who undergo a partial pancreatic resection. J Surg Res. 2014;187:189–96.PubMedGoogle Scholar
  93. 93.
    Dorlon M, Owczarski S, Wang H, et al. Increase in postoperative insulin requirements does not lead to decreased quality of life after total pancreatectomy with islet cell autotransplantation for chronic pancreatitis. Am Surg. 2013;79:676–80.PubMedGoogle Scholar
  94. 94.
    Roberts KJ, Blanco G, Webber J, et al. How severe is diabetes after total pancreatectomy? A case-matched analysis. HPB (Oxford). 2014;16:814–21.Google Scholar
  95. 95.
    Jamil LH, Chindris AM, Gill KR, et al. Glycemic control after total pancreatectomy for intraductal papillary mucinous neoplasm: an exploratory study. HPB Surg. 2012;2012:381328.PubMedCentralPubMedGoogle Scholar
  96. 96.
    Crippa S, Tamburrino D, Partelli S, et al. Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. Surgery. 2011;149:79–86.PubMedGoogle Scholar
  97. 97.
    Larsen S, Hilsted J, Philipsen EK, et al. A comparative study of microvascular complications in patients with secondary and type 1 diabetes. Diabet Med. 1990;7:815–8.PubMedGoogle Scholar
  98. 98.
    Levitt NS, Adams G, Salmon J, et al. The prevalence and severity of microvascular complications in pancreatic diabetes and IDDM. Diabetes Care. 1995;18:971–4.PubMedGoogle Scholar
  99. 99.
    Gasiorowska A, Czupryniak L, Malecka-Panas E, et al. [Microvascular complications in pancreatic diabetes]. Pol Arch Med Wewn. 2001;105:469–74.PubMedGoogle Scholar
  100. 100.
    Briani G, Riva F, Midena E, et al. Prevalence of microangiopathic complications in hyperglycemia secondary to pancreatic disease. J Diabet Complicat. 1988;2:50–2.Google Scholar
  101. 101.••
    Tiengo A, Segato T, Briani G, et al. The presence of retinopathy in patients with secondary diabetes following pancreatectomy or chronic pancreatitis. Diabetes Care. 1983;6:570–4. Demonstration that microvascular complications are present also in diabetes after pancreatic resection.PubMedGoogle Scholar
  102. 102.
    Couet C, Genton P, Pointel JP, et al. The prevalence of retinopathy is similar in diabetes mellitus secondary to chronic pancreatitis with or without pancreatectomy and in idiopathic diabetes mellitus. Diabetes Care. 1985;8:323–8.PubMedGoogle Scholar
  103. 103.
    Marre M, Hallab M, Roy J, et al. Glomerular hyperfiltration in type I, type II, and secondary diabetes. J Diabetes Complicat. 1992;6:19–24.PubMedGoogle Scholar
  104. 104.
    Mohan V, Ramachandran A, Viswanathan M. Two case reports of macrovascular complications in fibrocalculous pancreatic diabetes. Acta Diabetol Lat. 1989;26:345–9.PubMedGoogle Scholar
  105. 105.
    Wakasugi H, Hara Y, Abe M, Katsuda Y. Angiopathies in pancreatic diabetes resulting from chronic pancreatitis. Int J Pancreatol. 1998;23:175–80.PubMedGoogle Scholar
  106. 106.
    Ziegler O, Candiloros H, Guerci B, et al. Lower-extremity arterial disease in diabetes mellitus due to chronic pancreatitis. Diabete Metab. 1994;20:540–5.PubMedGoogle Scholar
  107. 107.
    Wakasugi H, Funakoshi A, Iguchi H. Clinical assessment of pancreatic diabetes caused by chronic pancreatitis. J Gastroenterol. 1998;33:254–9.PubMedGoogle Scholar
  108. 108.
    Ata A, Lee J, Bestle SL, et al. Postoperative hyperglycemia and surgical site infection in general surgery patients. Arch Surg. 2010;145:858–64.PubMedGoogle Scholar
  109. 109.
    Meynaar IA, Eslami S, Abu-Hanna A, et al. Blood glucose amplitude variability as predictor for mortality in surgical and medical intensive care unit patients: a multicenter cohort study. J Crit Care. 2012;27:119–24.PubMedGoogle Scholar
  110. 110.
    Hermanides J, Vriesendorp TM, Bosman RJ, et al. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38:838–42.PubMedGoogle Scholar
  111. 111.
    Dossett LA, Cao H, Mowery NT, et al. Blood glucose variability is associated with mortality in the surgical intensive care unit. Am Surg. 2008;74:679–85. discussion 685.PubMedGoogle Scholar
  112. 112.••
    van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67. Demonstration that intensive insulin therapy in critically ill patients increases survival.PubMedGoogle Scholar
  113. 113.
    Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180:821–7.PubMedCentralPubMedGoogle Scholar
  114. 114.••
    Eshuis WJ, Hermanides J, van Dalen JW, et al. Early postoperative hyperglycemia is associated with postoperative complications after pancreatoduodenectomy. Ann Surg. 2011;253:739–44. Demonstration that hyperglycemia is associated with postoperative complications after pancreatoduodenectomy.PubMedGoogle Scholar
  115. 115.
    Hanazaki K. Tight glycemic control using an artificial endocrine pancreas may play an important role in preventing infection after pancreatic resection. World J Gastroenterol. 2012;18:3787–9.PubMedCentralPubMedGoogle Scholar
  116. 116.
    Duncan AE. Hyperglycemia and perioperative glucose management. Curr Pharm Des. 2012;18:6195–203.PubMedCentralPubMedGoogle Scholar
  117. 117.
    Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283–97.PubMedGoogle Scholar
  118. 118.
    Okabayashi T, Shima Y, Sumiyoshi T, et al. Intensive versus intermediate glucose control in surgical intensive care unit patients. Diabetes Care. 2014;37:1516–24.PubMedGoogle Scholar
  119. 119.••
    Hanazaki K, Kitagawa H, Yatabe T, et al. Perioperative intensive insulin therapy using an artificial endocrine pancreas with closed-loop glycemic control system: the effects of no hypoglycemia. Am J Surg. 2014;207:935–41. Demonstration that intensive insulin therapy reduce perisurgical complications.PubMedGoogle Scholar
  120. 120.
    Choudhary P, Ramasamy S, Green L, et al. Real-time continuous glucose monitoring significantly reduces severe hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes. Diabetes Care. 2013;36:4160–2.PubMedCentralPubMedGoogle Scholar
  121. 121.
    Tran TC, van Lanschot JJ, Bruno MJ, van Eijck CH. Functional changes after pancreatoduodenectomy: diagnosis and treatment. Pancreatology. 2009;9:729–37.PubMedGoogle Scholar
  122. 122.
    Hamilton L, Jeyarajah DR. Hemoglobin A1c can be helpful in predicting progression to diabetes after Whipple procedure. HPB (Oxford). 2007;9:26–8.Google Scholar
  123. 123.
    Riediger H, Adam U, Fischer E, et al. Long-term outcome after resection for chronic pancreatitis in 224 patients. J Gastrointest Surg. 2007;11:949–59. discussion 959–60.PubMedGoogle Scholar
  124. 124.
    Najarian JS, Sutherland DE, Matas AJ, Goetz FC. Human islet autotransplantation following pancreatectomy. Transplant Proc. 1979;11:336–40.PubMedGoogle Scholar
  125. 125.
    Bramis K, Gordon-Weeks AN, Friend PJ, et al. Systematic review of total pancreatectomy and islet autotransplantation for chronic pancreatitis. Br J Surg. 2012;99:761–6.PubMedGoogle Scholar
  126. 126.
    Bellin MD, Beilman GJ, Dunn TB, et al. Islet autotransplantation to preserve beta cell mass in selected patients with chronic pancreatitis and diabetes mellitus undergoing total pancreatectomy. Pancreas. 2013;42:317–21.PubMedCentralPubMedGoogle Scholar
  127. 127.••
    Sutherland DE, Radosevich DM, Bellin MD, et al. Total pancreatectomy and islet autotransplantation for chronic pancreatitis. J Am Coll Surg. 2012;214:409–24. discussion 424–6. The largest cohort of patients undergoing islet autotransplantation for chronic pancreatitis.PubMedCentralPubMedGoogle Scholar
  128. 128.
    Bellin MD, Freeman ML, Schwarzenberg SJ, et al. Quality of life improves for pediatric patients after total pancreatectomy and islet autotransplant for chronic pancreatitis. Clin Gastroenterol Hepatol. 2011;9:793–9.PubMedCentralPubMedGoogle Scholar
  129. 129.
    Bellin MD, Carlson AM, Kobayashi T, et al. Outcome after pancreatectomy and islet autotransplantation in a pediatric population. J Pediatr Gastroenterol Nutr. 2008;47:37–44.PubMedGoogle Scholar
  130. 130.
    Webb MA, Illouz SC, Pollard CA, et al. Islet auto transplantation following total pancreatectomy: a long-term assessment of graft function. Pancreas. 2008;37:282–7.PubMedGoogle Scholar
  131. 131.
    Wilson GC, Sutton JM, Salehi M, et al. Surgical outcomes after total pancreatectomy and islet cell autotransplantation in pediatric patients. Surgery. 2013;154:777–83. discussion 783–4.PubMedGoogle Scholar
  132. 132.
    Sutton JM, Schmulewitz N, Sussman JJ, et al. Total pancreatectomy and islet cell autotransplantation as a means of treating patients with genetically linked pancreatitis. Surgery. 2010;148:676–85. discussion 685–6.PubMedGoogle Scholar
  133. 133.
    Clayton HA, Davies JE, Pollard CA, et al. Pancreatectomy with islet autotransplantation for the treatment of severe chronic pancreatitis: the first 40 patients at the Leicester General Hospital. Transplantation. 2003;76:92–8.PubMedGoogle Scholar
  134. 134.
    White SA, Davies JE, Pollard C, et al. Pancreas resection and islet autotransplantation for end-stage chronic pancreatitis. Ann Surg. 2001;233:423–31.PubMedCentralPubMedGoogle Scholar
  135. 135.
    Johnson PR, White SA, Robertson GS, et al. Pancreatic islet autotransplantation combined with total pancreatectomy for the treatment of chronic pancreatitis—the Leicester experience. J Mol Med (Berl). 1999;77:130–2.Google Scholar
  136. 136.
    Garcea G, Weaver J, Phillips J, et al. Total pancreatectomy with and without islet cell transplantation for chronic pancreatitis: a series of 85 consecutive patients. Pancreas. 2009;38:1–7.PubMedGoogle Scholar
  137. 137.
    Morgan KA, Nishimura M, Uflacker R, Adams DB. Percutaneous transhepatic islet cell autotransplantation after pancreatectomy for chronic pancreatitis: a novel approach. HPB (Oxford). 2011;13:511–6.Google Scholar
  138. 138.
    Ahmad SA, Lowy AM, Wray CJ, et al. Factors associated with insulin and narcotic independence after islet autotransplantation in patients with severe chronic pancreatitis. J Am Coll Surg. 2005;201:680–7.PubMedGoogle Scholar
  139. 139.
    Sutherland DE, Gruessner AC, Carlson AM, et al. Islet autotransplant outcomes after total pancreatectomy: a contrast to islet allograft outcomes. Transplantation. 2008;86:1799–802.PubMedGoogle Scholar
  140. 140.
    Dudeja V, Beilman GJ, Vickers SM. Total pancreatectomy with islet autotransplantation in patients with malignancy: are we there yet? Ann Surg. 2013;258:219–20.PubMedGoogle Scholar
  141. 141.••
    Balzano G, Maffi P, Nano R, et al. Extending indications for islet autotransplantation in pancreatic surgery. Ann Surg. 2013;258:210–8. The largest cohort of patients undergoing islet autotransplantation for pancreatic disease other than chronic pancreatitis.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Marina Scavini
    • 1
  • Erica Dugnani
    • 1
  • Valentina Pasquale
    • 1
  • Daniela Liberati
    • 1
  • Francesca Aleotti
    • 2
  • Gaetano Di Terlizzi
    • 3
  • Giovanna Petrella
    • 3
  • Gianpaolo Balzano
    • 2
  • Lorenzo Piemonti
    • 1
    Email author
  1. 1.Diabetes Research InstituteIRCCS San Raffaele Scientific InstituteMilanItaly
  2. 2.Pancreatic Surgery UnitMilanItaly
  3. 3.Department of OncologyIRCCS San Raffaele Scientific InstituteMilanItaly

Personalised recommendations